Guardant Health
GH
#2395
Rank
HK$46.23 B
Marketcap
HK$374.63
Share price
1.88%
Change (1 day)
163.09%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports (10-K)

Latest form 10-K annual reports for Guardant Health CIK: 0001576280

Thumbnail Guardant Health
 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)